Danaher (NYSE:DHR) Price Target Raised to $270.00 at HSBC

Danaher (NYSE:DHR) had its price target hoisted by stock analysts at HSBC from $255.00 to $270.00 in a report released on Monday,MarketScreener reports. The firm presently has a “buy” rating on the conglomerate’s stock. HSBC’s target price indicates a potential upside of 19.44% from the company’s previous close.

DHR has been the topic of several other reports. Royal Bank Of Canada set a $241.00 price objective on Danaher in a research report on Tuesday, September 2nd. Rothschild & Co Redburn restated a “neutral” rating and set a $220.00 target price (down previously from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Cowen reiterated a “buy” rating on shares of Danaher in a research note on Wednesday, October 22nd. Redburn Partners set a $220.00 target price on shares of Danaher in a report on Wednesday, October 8th. Finally, Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. Nineteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $244.70.

Danaher Stock Down 1.1%

DHR stock opened at $226.05 on Monday. Danaher has a twelve month low of $171.00 and a twelve month high of $258.23. The firm has a market cap of $159.67 billion, a PE ratio of 46.72, a price-to-earnings-growth ratio of 3.28 and a beta of 0.81. The business has a 50 day moving average of $212.20 and a 200 day moving average of $203.31. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.17. The firm had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.Danaher’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.71 EPS. On average, research analysts forecast that Danaher will post 7.63 EPS for the current fiscal year.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 3,298 shares of the firm’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the sale, the director directly owned 20,762 shares of the company’s stock, valued at $4,702,593. This trade represents a 13.71% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Brian W. Ellis sold 21,776 shares of the company’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the transaction, the senior vice president directly owned 14,553 shares of the company’s stock, valued at approximately $3,190,454.19. This trade represents a 59.94% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 30,248 shares of company stock worth $6,609,663. Corporate insiders own 11.10% of the company’s stock.

Institutional Investors Weigh In On Danaher

Institutional investors and hedge funds have recently modified their holdings of the stock. IFG Advisory LLC boosted its holdings in shares of Danaher by 49.0% during the 1st quarter. IFG Advisory LLC now owns 2,217 shares of the conglomerate’s stock valued at $454,000 after purchasing an additional 729 shares during the last quarter. Banco Santander S.A. lifted its position in shares of Danaher by 79.5% in the first quarter. Banco Santander S.A. now owns 15,721 shares of the conglomerate’s stock worth $3,223,000 after buying an additional 6,964 shares in the last quarter. Liberty Wealth Management LLC bought a new position in Danaher during the first quarter valued at approximately $3,494,000. Commonwealth Equity Services LLC grew its holdings in Danaher by 1.9% during the 1st quarter. Commonwealth Equity Services LLC now owns 144,868 shares of the conglomerate’s stock valued at $29,698,000 after buying an additional 2,753 shares in the last quarter. Finally, Earned Wealth Advisors LLC bought a new stake in Danaher in the 1st quarter worth approximately $241,000. Institutional investors own 79.05% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.